SEARCH

SEARCH BY CITATION

References

  • 1
    Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002; 21: 167178
  • 2
    Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760766
  • 3
    Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327336
  • 4
    Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee. An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005; 96: 13141318
  • 5
    Dalton CB, Drossman DA. Diagnosis and treatment of irritable bowel syndrome. Am Fam Physician 1997; 55: 875880, 883–5
  • 6
    Drossman DA, Whitehead WE, Camilleri M et al. Irritable bowel Syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 21202137
  • 7
    Heaton KW, Oettle GJ. Bowel symptoms and the pelvic floor. Lancet 1986; 24: 1207
  • 8
    Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci 1993; 38: 15811589
  • 9
    Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991; 100: 9981005
  • 10
    Miwa H. Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria. Patient Prefer Adherence 2008; 2: 143147
  • 11
    Whorwell PJ, Lupton EW, Erduran D, Wilson K. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut 1986; 27: 10141017
  • 12
    Cukier JM, Cortina-Borja M, Brading AF. A case-control study to examine any association between idiopathic detrusor instability and gastrointestinal tract disorder, and between irritable bowel syndrome and urinary tract disorder. Br J Urol 1997; 79: 865878
  • 13
    Whitehead WE, Palsson OS, Levy RR et al. Comorbidity in Irritable Bowel Syndrome. Am J Gastroenterol 2007; 102: 27672776
    Direct Link:
  • 14
    Agrawal A, Khan MH, Whorwell PJ. Irritable bowel syndrome in the elderly: a overlooked problem? Dig Liver Dis 2009; 41: 721724
  • 15
    Guo YJ, Ho CH, Chen SC et al. Lower urinary tract symptoms in women with irritable bowel syndrome. Int J Urol 2010; 17: 175181
  • 16
    Novi JM, Jeronis S, Srinivas S et al. Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study. J Urol 2005; 174: 937940
  • 17
    Nickel JC, Tripp DA, Pontari M et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 2010; 184: 13581363
  • 18
    Qin C, Malykhina AP, Akbarali HI, Foreman RD. Cross-organ sensitization of lumbosacral spinal neurons receiving urinary bladder input in rats with inflamed colon. Gastroenterology 2005; 129: 19671978
  • 19
    Bielefeldt K, Lamb K, Gebhart GF. Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. Am J Physiol 2006; 291: G658665
  • 20
    Qin C, Foreman RD. Viscerovisceral convergence of urinary bladder and colorectal inputs to lumbosacral spinal neurons in rats. Neuroreport 2004; 15: 467471
  • 21
    Christianson JA, Liang R, Ustinova EE et al. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain 2007; 128: 235243
  • 22
    Homma Y, Yoshida M, Seki N et al. Symptom assessment tool for overactive bladder syndrome – overactive bladder symptom score. Urology 2006; 68: 318323
  • 23
    Yamaguchi O, Nishizawa O, Takeda M et al. Clinical guidelines for overactive bladder. Int J Urol 2009; 16: 126142
  • 24
    Thompson WG, Drossman DA, Talley NJ et al. Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm. In Drossman DA , Corazziari E , Delvaux M et al. eds, Rome III; The Functional Gastrointestinal Disorders, 3rd edn. McLean: Degnon Associates, 2006: 917951
  • 25
    Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 14801491
  • 26
    Fukudo S, Hongo M, Matsueda K, Drossman DA. The Japanese Version of Rome III: the Functional Gastrointestinal Disorders, 3rd edn. Tokyo: KYOWA KIKAKU Ltd., 2008
  • 27
    Atkinson W, Lockhart S, Whorwell PJ et al. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 3443
  • 28
    Mariappan P, Alhasso A, Ballantyne Z et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 2007; 51: 6774
  • 29
    Coates MD, Mahoney CR, Linden DR et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 16571664
  • 30
    Garvin B, Wiley JW. The role of serotonin in irritable bowel syndrome: implications for management. Curr Gastroenterol Rep 2008; 10: 363368